PTC Therapeutics PTCT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $833.99M-43.7% | $984.65M+26.3% | $672.62M+27.9% | $1.02B+55.4% | $1.48B+170% | ||
| $1.06B+93.5% | $960.72M+167% | $1.02B+108% | $971.76M+122% | $546.95M+62.6% | ||
| $219.92M+4.5% | $181.62M+14.5% | $203.07M+1.5% | $196.13M+4.8% | $210.5M+6.5% | ||
| $75.57M+249% | $79.65M+243% | $52.69M+47.7% | $34.06M+7.0% | $21.68M-27.9% | ||
| $66.05M+15.8% | $67.31M+52.7% | $64.22M+97.3% | $53.53M+17.3% | $57.06M+1.5% | ||
| $2.25B-2.7% | $2.27B+66.5% | $2.01B+56.7% | $2.27B+67.4% | $2.32B+98.2% | ||
| $52.74M-11.3% | $55.37M-9.2% | $56.97M-9.8% | $57.19M-13.3% | $59.46M-35.9% | ||
| $76.69M+33.8% | $80.05M+41.2% | $80.68M+35.7% | $56.16M-1.7% | $57.32M-37.1% | ||
| $82.34M0.0% | $82.34M0.0% | $82.34M0.0% | $82.34M0.0% | $82.34M0.0% | ||
| $380.68M+221% | $388.75M+227% | $396.47M+20.0% | $143.81M-56.4% | $118.45M-64.1% | ||
| -$10K-600% | —— | —— | —— | $2K-100.0% | ||
| $2.87B+8.0% | $2.9B+70.0% | $2.64B+43.5% | $2.63B+37.5% | $2.66B+48.4% | ||
| $313.05M-1.5% | $381.27M+25.3% | $303.14M-9.9% | $338.95M0.0% | $317.81M-4.0% | ||
| $498K-96.1% | $2.04M-62.9% | $1.69M— | $9.76M— | $12.83M— | ||
| $286.94M+5,585% | $286.63M+9,454% | $286.32M+10,737% | $5.36M+134% | $5.05M+159% | ||
| $12.08M+5.4% | $12.48M+20.5% | $11.81M-16.3% | $11.73M-14.5% | $11.46M-21.3% | ||
| $6M+18.9% | $3M0.0% | $2.68M+1.3% | $5.36M+134% | $5.05M+159% | ||
| $923.6M+55.1% | $968.43M+66.7% | $866.25M+41.8% | $627.81M+3.0% | $595.39M+3.6% | ||
| $90.07M+22.4% | $93.58M+24.9% | $95.49M+15.4% | $71.24M-10.0% | $73.56M-29.8% | ||
| —— | $3M-80.7% | $13.83M-11.2% | $13.83M-11.2% | $13.83M-11.2% | ||
| $13.7M-38.9% | $13.7M-36.0% | $2.58M+3,249% | $7.82M+5,449% | $22.43M+15,807% | ||
| $3.05B+7.3% | $3.1B+10.7% | $2.8B-3.4% | $2.84B-1.9% | $2.84B+5.9% | ||
| $81K+3.8% | $80K+3.9% | $79K+3.9% | $78K+2.6% | $78K+2.6% | ||
| $2.78B+6.5% | $2.75B+6.7% | $2.67B+5.4% | $2.63B+4.8% | $2.61B+4.9% | ||
| -$2.97B-6.7% | -$2.96B+18.7% | -$2.83B+21.0% | -$2.85B+18.1% | -$2.78B+17.6% | ||
| $8.47M+161% | $10.5M+141% | $5.93M+237% | $7.36M+145% | -$13.95M-151% | ||
| -$180.47M+2.9% | -$205.31M+81.3% | -$155.76M+85.2% | -$206.55M+78.9% | -$185.76M+79.2% | ||
| $2.87B+8.0% | $2.9B+70.0% | $2.64B+43.5% | $2.63B+37.5% | $2.66B+48.4% | ||
| $1.06B+93.5% | $960.72M+167% | $1.02B+108% | $971.76M+122% | $546.95M+62.6% | ||
| $76.69M+33.8% | $80.05M+41.2% | $80.68M+35.7% | $56.16M-1.7% | $57.32M-37.1% | ||
| $22.65M+5.7% | $18.3M-11.6% | $19.44M-23.3% | $21.78M-5.7% | $21.42M-12.7% | ||
| $380.68M+221% | $388.75M+227% | $396.47M+20.0% | $143.81M-56.4% | $118.45M-64.1% | ||
| $76.69M+33.8% | $80.05M+41.2% | $80.68M+35.7% | $56.16M-1.7% | $57.32M-37.1% | ||
| $76.69M+33.8% | $80.05M+41.2% | $80.68M+35.7% | $56.16M-1.7% | $57.32M-37.1% | ||
| $313.05M-1.5% | $381.27M+25.3% | $303.14M-9.9% | $338.95M0.0% | $317.81M-4.0% | ||
| $305.04M+22.9% | $283M+9.8% | $260.61M+1.2% | $262.02M+2.8% | $248.24M+9.3% | ||
| $395.09M+0.1% | $398.7M+1.6% | $410.13M+1.8% | $393.52M-1.1% | $394.66M-6.8% | ||
| $81K+3.8% | $80K+3.9% | $79K+3.9% | $78K+2.6% | $78K+2.6% | ||
| $6M+18.9% | $3M0.0% | $2.68M+1.3% | $5.36M+134% | $5.05M+159% | ||
| $2.02B+9.3% | $2.03B+11.0% | $1.82B-0.2% | $1.83B+0.2% | $1.85B+14.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are PTC Therapeutics's total assets?
- PTC Therapeutics (PTCT) holds $2.9B in total assets, up 8.1% year over year.
- How much debt does PTC Therapeutics have?
- PTC Therapeutics carries $395.1M in total debt against -$180.5M of shareholders' equity, a debt-to-equity ratio of 372.31.
- How much cash does PTC Therapeutics have?
- PTC Therapeutics holds $834.0M in cash and equivalents.
- Can PTC Therapeutics cover its short-term obligations?
- Its current ratio is 2.44 — current assets exceed current liabilities.
- Where does PTC Therapeutics's balance sheet data come from?
- Every line is extracted from PTC Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
